Diabetes Testing Systems are the systems used at home or health care settings for monitoring the blood glucose levels in diabetic patients. Testing blood glucose level is the best way to understand diabetes and how different foods, medications, and other activities affect diabetes.
The global market for Diabetes Testing System was estimated to be worth US$ 3300 million in 2023 and is forecast to a readjusted size of US$ 5987.7 million by 2030 with a CAGR of 8.9% during the forecast period 2024-2030
The market for diabetes testing systems has been witnessing significant growth in recent years due to the increasing prevalence of diabetes and the growing awareness about the importance of regular monitoring of blood glucose levels. According to the International Diabetes Federation, the number of people with diabetes is projected to reach 700 million by 2045.
The market is driven by factors such as the rising geriatric population, sedentary lifestyles, unhealthy dietary habits, and the increasing prevalence of obesity. Additionally, advancements in technology have led to the development of innovative glucose monitoring systems that offer better accuracy, convenience, and ease of use.
Key players in the global diabetes testing system market include Abbott Laboratories, Roche Diagnostics, Dexcom, Inc., Medtronic plc, Ascensia Diabetes Care Holdings AG, Johnson & Johnson, and Becton, Dickinson and Company, among others. These companies invest in research and development activities to introduce new and advanced diabetes testing systems in the market.
The market is segmented based on product type, which includes self-monitoring blood glucose systems, continuous glucose monitoring systems, and others. Geographically, North America holds a significant share in the market, followed by Europe and the Asia Pacific region.
The global diabetes testing system market is anticipated to witness continued growth in the coming years, driven by the increasing prevalence of diabetes and the continuous efforts of market players to develop and commercialize innovative testing systems.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Diabetes Testing System, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Diabetes Testing System by region & country, by Type, and by Application.
The Diabetes Testing System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Testing System.
Market Segmentation
By Company
Roche Holding AG
Abbott Laboratories
Sanofi S.A.
ACON Laboratories
Nova Biomedical
Nipro Corporation
Braun Holding GmbH
DexCom
Medtronic Plc
ARKRAY
LifeScan
Ascensia Diabetes Care
Segment by Type:
Self-Monitoring Diabetes Testing Systems
Continuous Diabetes Testing Systems
Others
Segment by Application
Home Care
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Diabetes Testing System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Diabetes Testing System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Diabetes Testing System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Diabetes Testing System Product Introduction
1.2 Global Diabetes Testing System Market Size Forecast
1.2.1 Global Diabetes Testing System Sales Value (2019-2030)
1.2.2 Global Diabetes Testing System Sales Volume (2019-2030)
1.2.3 Global Diabetes Testing System Sales Price (2019-2030)
1.3 Diabetes Testing System Market Trends & Drivers
1.3.1 Diabetes Testing System Industry Trends
1.3.2 Diabetes Testing System Market Drivers & Opportunity
1.3.3 Diabetes Testing System Market Challenges
1.3.4 Diabetes Testing System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Diabetes Testing System Players Revenue Ranking (2023)
2.2 Global Diabetes Testing System Revenue by Company (2019-2024)
2.3 Global Diabetes Testing System Players Sales Volume Ranking (2023)
2.4 Global Diabetes Testing System Sales Volume by Company Players (2019-2024)
2.5 Global Diabetes Testing System Average Price by Company (2019-2024)
2.6 Key Manufacturers Diabetes Testing System Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Diabetes Testing System Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Diabetes Testing System
2.9 Diabetes Testing System Market Competitive Analysis
2.9.1 Diabetes Testing System Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Diabetes Testing System Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Testing System as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Self-Monitoring Diabetes Testing Systems
3.1.2 Continuous Diabetes Testing Systems
3.1.3 Others
3.2 Global Diabetes Testing System Sales Value by Type
3.2.1 Global Diabetes Testing System Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Diabetes Testing System Sales Value, by Type (2019-2030)
3.2.3 Global Diabetes Testing System Sales Value, by Type (%) (2019-2030)
3.3 Global Diabetes Testing System Sales Volume by Type
3.3.1 Global Diabetes Testing System Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Diabetes Testing System Sales Volume, by Type (2019-2030)
3.3.3 Global Diabetes Testing System Sales Volume, by Type (%) (2019-2030)
3.4 Global Diabetes Testing System Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Home Care
4.1.2 Hospitals
4.1.3 Clinics
4.1.4 Others
4.2 Global Diabetes Testing System Sales Value by Application
4.2.1 Global Diabetes Testing System Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Diabetes Testing System Sales Value, by Application (2019-2030)
4.2.3 Global Diabetes Testing System Sales Value, by Application (%) (2019-2030)
4.3 Global Diabetes Testing System Sales Volume by Application
4.3.1 Global Diabetes Testing System Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Diabetes Testing System Sales Volume, by Application (2019-2030)
4.3.3 Global Diabetes Testing System Sales Volume, by Application (%) (2019-2030)
4.4 Global Diabetes Testing System Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Diabetes Testing System Sales Value by Region
5.1.1 Global Diabetes Testing System Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Diabetes Testing System Sales Value by Region (2019-2024)
5.1.3 Global Diabetes Testing System Sales Value by Region (2025-2030)
5.1.4 Global Diabetes Testing System Sales Value by Region (%), (2019-2030)
5.2 Global Diabetes Testing System Sales Volume by Region
5.2.1 Global Diabetes Testing System Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Diabetes Testing System Sales Volume by Region (2019-2024)
5.2.3 Global Diabetes Testing System Sales Volume by Region (2025-2030)
5.2.4 Global Diabetes Testing System Sales Volume by Region (%), (2019-2030)
5.3 Global Diabetes Testing System Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Diabetes Testing System Sales Value, 2019-2030
5.4.2 North America Diabetes Testing System Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Diabetes Testing System Sales Value, 2019-2030
5.5.2 Europe Diabetes Testing System Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Diabetes Testing System Sales Value, 2019-2030
5.6.2 Asia Pacific Diabetes Testing System Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Diabetes Testing System Sales Value, 2019-2030
5.7.2 South America Diabetes Testing System Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Diabetes Testing System Sales Value, 2019-2030
5.8.2 Middle East & Africa Diabetes Testing System Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Diabetes Testing System Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Diabetes Testing System Sales Value
6.2.1 Key Countries/Regions Diabetes Testing System Sales Value, 2019-2030
6.2.2 Key Countries/Regions Diabetes Testing System Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Diabetes Testing System Sales Value, 2019-2030
6.3.2 United States Diabetes Testing System Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Diabetes Testing System Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Diabetes Testing System Sales Value, 2019-2030
6.4.2 Europe Diabetes Testing System Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Diabetes Testing System Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Diabetes Testing System Sales Value, 2019-2030
6.5.2 China Diabetes Testing System Sales Value by Type (%), 2023 VS 2030
6.5.3 China Diabetes Testing System Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Diabetes Testing System Sales Value, 2019-2030
6.6.2 Japan Diabetes Testing System Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Diabetes Testing System Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Diabetes Testing System Sales Value, 2019-2030
6.7.2 South Korea Diabetes Testing System Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Diabetes Testing System Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Diabetes Testing System Sales Value, 2019-2030
6.8.2 Southeast Asia Diabetes Testing System Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Diabetes Testing System Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Diabetes Testing System Sales Value, 2019-2030
6.9.2 India Diabetes Testing System Sales Value by Type (%), 2023 VS 2030
6.9.3 India Diabetes Testing System Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Roche Holding AG
7.1.1 Roche Holding AG Company Information
7.1.2 Roche Holding AG Introduction and Business Overview
7.1.3 Roche Holding AG Diabetes Testing System Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Roche Holding AG Diabetes Testing System Product Offerings
7.1.5 Roche Holding AG Recent Development
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Information
7.2.2 Abbott Laboratories Introduction and Business Overview
7.2.3 Abbott Laboratories Diabetes Testing System Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Laboratories Diabetes Testing System Product Offerings
7.2.5 Abbott Laboratories Recent Development
7.3 Sanofi S.A.
7.3.1 Sanofi S.A. Company Information
7.3.2 Sanofi S.A. Introduction and Business Overview
7.3.3 Sanofi S.A. Diabetes Testing System Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sanofi S.A. Diabetes Testing System Product Offerings
7.3.5 Sanofi S.A. Recent Development
7.4 ACON Laboratories
7.4.1 ACON Laboratories Company Information
7.4.2 ACON Laboratories Introduction and Business Overview
7.4.3 ACON Laboratories Diabetes Testing System Sales, Revenue and Gross Margin (2019-2024)
7.4.4 ACON Laboratories Diabetes Testing System Product Offerings
7.4.5 ACON Laboratories Recent Development
7.5 Nova Biomedical
7.5.1 Nova Biomedical Company Information
7.5.2 Nova Biomedical Introduction and Business Overview
7.5.3 Nova Biomedical Diabetes Testing System Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Nova Biomedical Diabetes Testing System Product Offerings
7.5.5 Nova Biomedical Recent Development
7.6 Nipro Corporation
7.6.1 Nipro Corporation Company Information
7.6.2 Nipro Corporation Introduction and Business Overview
7.6.3 Nipro Corporation Diabetes Testing System Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Nipro Corporation Diabetes Testing System Product Offerings
7.6.5 Nipro Corporation Recent Development
7.7 Braun Holding GmbH
7.7.1 Braun Holding GmbH Company Information
7.7.2 Braun Holding GmbH Introduction and Business Overview
7.7.3 Braun Holding GmbH Diabetes Testing System Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Braun Holding GmbH Diabetes Testing System Product Offerings
7.7.5 Braun Holding GmbH Recent Development
7.8 DexCom
7.8.1 DexCom Company Information
7.8.2 DexCom Introduction and Business Overview
7.8.3 DexCom Diabetes Testing System Sales, Revenue and Gross Margin (2019-2024)
7.8.4 DexCom Diabetes Testing System Product Offerings
7.8.5 DexCom Recent Development
7.9 Medtronic Plc
7.9.1 Medtronic Plc Company Information
7.9.2 Medtronic Plc Introduction and Business Overview
7.9.3 Medtronic Plc Diabetes Testing System Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Medtronic Plc Diabetes Testing System Product Offerings
7.9.5 Medtronic Plc Recent Development
7.10 ARKRAY
7.10.1 ARKRAY Company Information
7.10.2 ARKRAY Introduction and Business Overview
7.10.3 ARKRAY Diabetes Testing System Sales, Revenue and Gross Margin (2019-2024)
7.10.4 ARKRAY Diabetes Testing System Product Offerings
7.10.5 ARKRAY Recent Development
7.11 LifeScan
7.11.1 LifeScan Company Information
7.11.2 LifeScan Introduction and Business Overview
7.11.3 LifeScan Diabetes Testing System Sales, Revenue and Gross Margin (2019-2024)
7.11.4 LifeScan Diabetes Testing System Product Offerings
7.11.5 LifeScan Recent Development
7.12 Ascensia Diabetes Care
7.12.1 Ascensia Diabetes Care Company Information
7.12.2 Ascensia Diabetes Care Introduction and Business Overview
7.12.3 Ascensia Diabetes Care Diabetes Testing System Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Ascensia Diabetes Care Diabetes Testing System Product Offerings
7.12.5 Ascensia Diabetes Care Recent Development
8 Industry Chain Analysis
8.1 Diabetes Testing System Industrial Chain
8.2 Diabetes Testing System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Diabetes Testing System Sales Model
8.5.2 Sales Channel
8.5.3 Diabetes Testing System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Roche Holding AG
Abbott Laboratories
Sanofi S.A.
ACON Laboratories
Nova Biomedical
Nipro Corporation
Braun Holding GmbH
DexCom
Medtronic Plc
ARKRAY
LifeScan
Ascensia Diabetes Care
听
听
*If Applicable.
